Mutation-centric kinase drug repurposing for rare cancers.
Saved in:
| Title: | Mutation-centric kinase drug repurposing for rare cancers. |
|---|---|
| Authors: | Chan M; Division of Human Biology, Fred Hutchinson Cancer Center, Seattle, WA, USA., Ma H; Reaction Biology, Malvern, PA, USA., Subbiah V; Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Gujral TS; Division of Human Biology, Fred Hutchinson Cancer Center, Seattle, WA, USA. tgujral@fredhutch.org. |
| Source: | Nature reviews. Cancer [Nat Rev Cancer] 2026 Jul; Vol. 26 (7), pp. 473-474. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101124168 Publication Model: Print Cited Medium: Internet ISSN: 1474-1768 (Electronic) Linking ISSN: 1474175X NLM ISO Abbreviation: Nat Rev Cancer Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
| ISSN: | 1474-1768 |
|---|---|
| DOI: | 10.1038/s41568-026-00944-w |
